Thermo commits to fixing software glitch within 8 weeks

Thermo Fisher Scientific ($TMO) has confirmed its Kinetica software will generate inaccurate results when analyzing unbalanced clinical trials, Reuters reports. The company thinks the glitch is unlikely to have caused significant discrepancies and it expects to fix the problem by updating the software within 8 weeks. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.